Versant Capital Management, Inc Edwards Lifesciences Corp Transaction History

Versant Capital Management, Inc

  • $454 Million
  • Q4 2024

A detailed history of Versant Capital Management, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,553 shares of EW stock, worth $118,323. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,553
Previous 767 102.48%
Holding current value
$118,323
Previous $50,000 128.0%
% of portfolio
0.03%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025
BUY
$64.54 - $75.92 $50,728 - $59,673
786 Added 102.48%
1,553 $114,000
Q3 2024

Oct 07, 2024
BUY
$59.7 - $93.78 $16,895 - $26,539
283 Added 58.47%
767 $50,000
Q2 2024

Jul 05, 2024
BUY
$84.3 - $94.31 $27,481 - $30,745
326 Added 206.33%
484 $44,000
Q1 2024

Apr 03, 2024
BUY
$72.54 - $95.56 $8,124 - $10,702
112 Added 243.48%
158 $15,000
Q4 2023

Jan 08, 2024
BUY
$61.71 - $77.76 $617 - $777
10 Added 27.78%
46 $3,000
Q3 2023

Oct 11, 2023
SELL
$69.28 - $93.38 $207 - $280
-3 Reduced 7.69%
36 $2,000
Q2 2023

Jul 10, 2023
BUY
$81.41 - $94.33 $732 - $848
9 Added 30.0%
39 $3,000
Q4 2022

Jan 25, 2023
SELL
$68.3 - $87.44 $614 - $786
-9 Reduced 23.08%
30 $0
Q3 2022

Dec 30, 2022
SELL
$82.37 - $107.29 $1,317 - $1,716
-16 Reduced 29.09%
39 $3,000
Q1 2022

Apr 29, 2022
SELL
$101.96 - $128.34 $2,243 - $2,823
-22 Reduced 28.57%
55 $6,000
Q3 2021

Oct 29, 2021
SELL
$102.91 - $122.75 $1,646 - $1,964
-16 Reduced 17.2%
77 $9,000
Q2 2020

Jul 16, 2020
BUY
$57.54 - $76.95 $3,567 - $4,770
62 Added 200.0%
93 $6,000
Q1 2020

Apr 17, 2020
BUY
$52.41 - $81.0 $419 - $648
8 Added 34.78%
31 $5,000
Q2 2019

Jul 16, 2019
SELL
$55.74 - $64.41 $9,308 - $10,756
-167 Reduced 87.89%
23 $4,000
Q1 2019

Apr 23, 2019
SELL
$47.89 - $64.05 $7,375 - $9,863
-154 Reduced 81.05%
36 $36,000
Q1 2019

Apr 23, 2019
BUY
$47.89 - $64.05 $7,375 - $9,863
154 Added 427.78%
190 $36,000
Q3 2018

Oct 15, 2018
SELL
$45.7 - $58.03 $182 - $232
-4 Reduced 2.06%
190 $33,000
Q2 2017

Apr 23, 2018
SELL
N/A
-22 Reduced 10.19%
194 $22,000
Q3 2016

Apr 23, 2018
SELL
N/A
-7 Reduced 3.14%
216 $26,000
Q1 2016

Apr 23, 2018
BUY
N/A
17 Added 8.25%
223 $19,000
Q4 2015

Apr 23, 2018
BUY
N/A
206
206 $16,000

Others Institutions Holding EW

# of Institutions
1,381
Shares Held
474M
Call Options Held
8.62M
Put Options Held
4.03M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $47.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email